Treatment of hypertension in older patients

Main Article Content

O. M. Kovalyova


The article is dedicated to the strategy of management of arterial hypertension in older patients based on the Guidelines of the International Society of Hypertension, the European Society of Cardiology, the European and the American Society of Hypertension, the American College of Physicians and the American Academy of Family Physicians. According to the results of epidemiological and clinical investigations is shown the influence of high blood pressure on cardiovascular outcomes and mortality in the population of older persons. Due to the analyses of randomised controlled trials is pointed out the convicing data the need for differtntiated control of blood pressure according to the level of arterial hypertension and factors of cardiovascular risk. The methodology of initial antihypertensive therapy in persons of different age groups is taken in comparative aspects. The main discussed questions related to the blood pressure targets in the dynamics of antihypertensive treatment in patients 65–79 years and age ≥ 80 years are emphasized. The requirements for individual medical tactics of older hypertensive patients taken into account anamnesis, fit and mental state, clinical features, comorbidity, complications and hypertension-mediated organ damages are recommended.

Article Details


arterial hypertension, old age, antihypertensive treatment, blood pressure targets


Aronow W., Fleg J., Pepine C. et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents // Circulation.– 2011.– Vol. 123.– P. 2434–2506.

Bakris G., Briasoulis A. Searching for the Optimal Blood Pressure in the Elderly // J. Amer. Coll. Cardiology.– 2017.– Vol. 69.– P. 1–5.

Beckett N., Peters R., Leonetti G. et al., HYVET Study Group. Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial // J. Hypertension.– 2014.– Vol. 32.– P. 1478–1487.

Borghi С., Tartagni Е., Borghi C. et al. The older patient with hypertension: care and cure // Ther. Adv. Chronic. Dis.– 2012.– Vol. 3 (5).– P. 231–236.

Briasoulis A., Agarwal V., Tousoulis D. et al. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies // Heart.– 2014.– Vol. 100.– P. 317–323. doi:

Brown M., David W., Giles Wayne H. Blood pressure parameters and risk of fatal stroke, NHANES ІІ mortality study // Am. J. Hypertension.– 2007.– Vol. 20.– P. 338–341.

Bulletin of the World Health Organization.– 1999.– Р. 77 (3).

Chow C.K., Teo K.K., Rangarajan S. et al. PURE Study Investigators. Prevalence, awareness, treatment and control of hypertension in rural and urban communities in high-, middle-, and low-income countries // JAMA.– 2013.– Vol. 310.– P. 959–968.

Corrao G., Rea F., Monzio Compagnoni M. et al. Protective effects of antihypertensive treatment in patients aged 85 years or older // J. Hypertension.– 2017.– Vol. 35 (7).– P. 1432–1441. doi:

Ettehad D., Emdin C., Kiran A. et al. Blood pressure lowering for prevention of cardiovascular disease and death: a sys­­tematic review and meta-analysis // Lancet.– 2016.– Vol. 387.– P. 957–967. doi:

Franklin S.S., Gustin W., Wong N.D. et al. Hemodynamic patterns of age-related changes in blood pressure the Fremingham Study // Circulation.– 1997.– Vol. 96.– P. 308–315.

Franklin S.S., Larson M.G., Khan S.A. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study // Circulation.– 2001.– Vol. 103.– P. 1245–1249.

Gensini G.F., Corradi F. Hypertension as a function of age // Ital. Heart J.– 2000.– Vol. 1, Suppl. 2.– P. 23–31.

Global Burden of Disease Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 // Lancet.– 2018.– Vol. 392.– P. 1923–1994. doi:

James P., Oparil S., Carter B. et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8) // JAMA.– 2014.– Vol. 311.– P. 507–520.

Lonn E.M., Bosch J., Lopez-Jaramillo P. et al. HOPE-3 Investigators. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease // New Engl. J. Med.– 2016.– Vol. 374.– P. 2009–2020. doi:

Mancia G., De Backer G., Dominiczak A. et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the

European Society of Cardiology (ESC) // Hypertension.– 2007.– Vol. 25.– P. 1105–1187.

Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Eur. Heart J.– 2013.– Vol. 34.– P. 2159–2219.

NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants // Lancet.– 2017.– Vol. 389.– P. 37–55. doi:

Nichols M., Townsend N., Scarborough P. et al. Cardio­­vascular disease in Europe 2014: epidemiological update // Eur. Heart J.– 2014.– Vol. 35.– P. 2950–2959. doi:

Qaseem A., Wilt T.J., Rich R. et al. Treatment of Hypertension in Adults Aged 60 years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians // Ann. Intern. Med.– 2017.– Vol. 166 (6).– P. 430–437. doi:

Research Group SPRINT, Wright J.T. Jr., Williamson J.D., Whelton P.K. et al. A randomized trial of intensive versus standard blood-pressure control // New Engl. J. Med.– 2015.– Vol. 373.– P. 2103–2116. doi:

Sundstrom J., Arima H., Jackson R. et al., Blood Pressure-Lowering Treatment Trialists’ Collaboration. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis // Ann. Intern. Med.– 2015.– Vol. 162.– P. 184–191. doi:

Thomopoulos C., Parati G., Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. Overview, meta-analyses, and meta-regression analyses of randomized trials // J. Hypertension.– 2014.– Vol. 32.– P. 2296–2304. doi:

Unger T., Borghi C., Charchar F. et al. 2020 International Society of Hypertension global hypertension practice guidelines // J. Hypertension.– 2020.– Vol. 38, Issue 6.– P. 982–1004. doi:

Ungvari Z., Kaley G., de Cabo R. et al. A Mechanisms of vascular aging: new perspectives // J. Gerontol. A Biol Sci Med. Sci.– 2010.– Vol. 65.– P. 1028–1041.

Williams B., Mancia G., Spiering W. et al. 2018 ЕSC/ESH Guidelines for the management of arterial hypertension TheTask Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension // J. Hypertension.– 2018.– Vol. 36.– Р. 1953–2041. doi:

Williamson J.D., Supiano M.A., Applegate W.B. et al. SPRINT Research Group. Intensive vs standard blood pressure control and сardiovascular disease outcomes in adults aged 75 years: a randomized clinical trial // JAMA.– 2016.– Vol. 315.– P. 2673–2682. doi:

Xu X., Wang B., Ren C. et al. Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases // Aging Dis.– 2017.– Vol. 8 (4).– P. 486–505. doi: